From AVAC <[email protected]>
Subject AVAC’s Guide to AIDS 2024 in Munich
Date July 15, 2024 3:32 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
AVAC’s Guide to AIDS 2024 in Munich ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌

View this email in your browser ([link removed])
[link removed] July 15, 2024


** AVAC’s Guide to AIDS 2024 in Munich
------------------------------------------------------------

Dear Advocate,

More than 15,000 attendees will convene in Munich, Germany and virtually July 22 – 26 for AIDS 2024 ([link removed]) , the world’s largest conference on HIV/AIDS. This 25th edition of the conference will kickoff with a full agenda of pre-conference sessions July 20 and 21. 

The conference occurs on the heels of the PURPOSE 1 PrEP trial announcement ([link removed]) , along with the publication of our new primer ([link removed]) and joint civil society statement ([link removed]) . AVAC will be tracking discussion, debate and decision making on what’s next and how urgently the field moves to make the full range of PrEP options feasible choices for all people who need and want HIV prevention. We’ll also be following the latest scientific and policy advances, efforts in decolonizing global health, successes in community-led initiatives, and much more.

Read on for resources and ways to navigate AIDS 2024.
[link removed]
Resources

• Use AVAC’s Prevention Roadmap ([link removed]) for a curated rundown on all things prevention at AIDS 2024. You can download it as a sortable spreadsheet or pdf.
• The Research-to-Rollout Literacy Networking Zone ([link removed]) , convened by AVAC and CASPR partners, will offer in-person and virtual programming including sessions on PrEP, the Dual Prevention Pill, HIV vaccine and cure research and more!
• Follow events in real time on Twitter at ([link removed]) #AIDS2024 ([link removed]) and Instagram ([link removed]) . See AVAC’s comments and updates by following us at @HIVpxresearch ([link removed]) , find updates to these resources on our AIDS 2024 page ([link removed]) .

[link removed]
Pre-conferences, Satellites, Sessions and Workshops Featuring AVAC and Partners


** Saturday, 20 July
------------------------------------------------------------

Pre-conference: Key Populations and HIV Prevention Pre-Conference ([link removed]) , 08:00 – 16:00 CEST

Hosted by the Global Black Gay Men Connect (GBGMC) and Global KP HIV Prevention Advisory Group in partnership with AVAC, Fierte Afrique, CoalitionPlus, EpiC Project and Palladium, this day-long session will "demand and deliver: securing rights, funding and prevention" will cover rights, funding and prevention to ensure that key populations are not left behind.


Pre-conference: Welcome to the Era of PrEP choice, ([link removed]) 08:00 – 16:30 CEST

Hosted by the Bill & Melinda Gates Foundation, Unitaid, USAID, WHO and partners, this session covers the PrEP pipeline, learnings from the early delivery of oral PrEP and what’s needs to happen to ensure expeditious access to the range of PrEP options for all.


** Sunday, 21 July
------------------------------------------------------------

Pre-conference: Mobilize for action on sexually transmitted infections ([link removed]) , 08:00 – 16:30 CEST

Organized by WHO, IAS and International Union against Sexually Transmitted Infections (IUSTI), this session will share insights into the global impact of sexually transmitted infections (STIs), featuring new developments in STIs, including the latest WHO guidelines, what we know and don’t know about antimicrobial resistance and the use of DoxyPEP.

Pre-conference: Towards a truly global HIV cure ([link removed]) , 09:00 – 16:30 CEST

This pre-conference will reflect on current research directions, scientific and structural challenges associated with conducting HIV cure research and the importance of expanding and coordinating efforts across countries and regions.


** Monday, 22 July
------------------------------------------------------------

Satellite: New ways for the next wave: Innovative R&D for the future of women's prevention ([link removed]) , 09:30 – 10:30 CEST

Organized by CASPR ([link removed]) (Coalition to Accelerate & Support Prevention Research) and MATRIX ([link removed]) (Microbicide R&D to Advance HIV Prevention Technologies through Responsive Innovation and Excellence), this session will focus on new efforts to identify and develop promising women’s prevention options, strategically engage all stakeholders, decolonize R&D and involve potential users in all their diversities throughout the process.

Satellite: Money, money, money: Building towards a sustainable end state for HIV prevention ([link removed]) , 15:00 – 16:30 CEST

As we look to 2030 and given stagnating or decreasing donor resources, we now face the question of how to ensure lasting impact with sustained access to PrEP. Hosted by AVAC, PATH, USAID, WHO and partners, this dynamic session will highlight critical HIV prevention financing gaps and showcase innovative financing and delivery solutions being rolled out to advance sustainable preventive services.


** Wednesday, 24 July
------------------------------------------------------------

Workshop: Two for the price of one: Simplifying access to HIV prevention and contraception with multipurpose prevention technologies ([link removed]) , 10:00 – 11:30 CEST

Organized by AVAC, IPPF, Population Council, Clinton Health Access Initiative and partners, this workshop will leverage the expertise of HIV and sexual and reproductive health stakeholders to examine strategies for successfully introducing the Dual Prevention Pill (DPP) and use it as a model for delivering future MPTs.

Special Session: AIDS 2024 Co-Chairs' Choice ([link removed]) , 10:30 – 12:00 CEST

Among exciting new developments, Linda Gail-Bekker will present, Twice-Yearly Lenacapavir or Daily Emtricitabine/Tenofovir Alafenamide for HIV Prevention in Cisgender Women: Interim Analysis Results from the PURPOSE 1 Study.

Satellite: People-centred and sustainable HIV prevention: Towards a new generation of prevention responses in a changing epidemic context ([link removed]) , 12:00 – 13:00 CEST

Building on latest evidence and mathematical modelling analyses, this session will outline a new generation of people-centred and sustainable prevention, which will build on precise analysis of the epidemic and consider differentiated people-centered packages of services, delivery modalities and outreach. It’s hosted by the Bill & Melinda Gates Foundation, Global Prevention Coalition, UNAIDS and UNFPA.


** Thursday, 25 July
------------------------------------------------------------

Satellite: HIV prevention in the time of choice ([link removed]) , 07:00 – 08:00 CEST

Organized by the African Women Prevention Accountability Board (AWPCAB) and IPM South Africa, this session will feature an expert panel discussing what is needed to make the current options available for all women and how to balance resources for expanding access to existing methods while simultaneously developing new methods.

Oral abstract: Integrating social enterprise for sustainability of key population programmes, ([link removed]) 15:00- 16:00

AVAC’s, Richard Muko will present the abstract, Country HIV response sustainability roadmaps: where are key populations in the conversations ([link removed]) , which shares insights from a cross-country collaboration ([link removed]) strengthening advocacy for key populations.

Satellite: Ending AIDS as a public health threat: The role of a vaccine in the era of long-acting PrEP ([link removed]) , 18:00 – 19:00

This session will bring together global experts and community stakeholders to tackle this question. Panelists will discuss emerging evidence and engage in lively debate on the potential need for and pathway to an HIV vaccine.
Find these resources, conference highlights and more at AVAC’s dedicated AIDS 2024 event page. ([link removed]) And watch this space for new opportunities to come together and shape what happens next.

Best,

AVAC
Follow us @hivpxresearch ([link removed])
[link removed] [link removed] [link removed]
Share this issue ([link removed]) [link removed]
AVAC Global Advocacy for HIV Prevention
+1 212 796 6423 [email protected] (mailto:[email protected]) www.avac.org ([link removed])
You're receiving this because you signed up for our newsletter. Not interested any longer?
Manage email preferences ([link removed]) | Unsubscribe ([link removed])
Screenshot of the email generated on import

Message Analysis